Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
U.S. Army honors Wisconsin son, killed on an Italian battlefield in WWI
DVIDS - Georgia
U.S. Army honors Wisconsin son, killed on an Italian battlefield in WWI By Staff Sgt. Richard Cole, U.S. Army Garrison Italy SAN DONÀ DI PIAVE, Italy – Lt. Edward Michael McKey, an American Red Cross volunteer, arrived in Italy with a simple...
Healthcare Cloud Computing Market to Reach US$ 71.30 Billion by 2034 at 12.16% CAGR, Driven by Growing Adoption of Digital Health Platforms and Healthcare Data Management Solutions | Exclusive Report by The Insight Partners
GlobeNewswire, Inc.
New York, Nov. 05, 2026 (GLOBE NEWSWIRE) -- The global Healthcare Cloud Computing Market is projected to grow from US$ 25.39 billion in 2025 to US$ 71.30 billion by 2034, registering a CAGR of 12.16% during 2026 to 2034, according to a new market...
Nxera Pharma Announces Vamorolone Selected for South Korea’s Accelerated Reimbursement Pilot Program for Rare Disease Treatments
GlobeNewswire, Inc.
Vamorolone is one of five treatments selected for the rare disease reimbursement pilot program.
Five Reputable Modular Medical Storage System Manufacturers in 2026: Advancing Flexible, Infection-Safe Infrastructure
EIN Presswire
A closer look at how five manufacturers are supporting space flexibility, infection control, and regulatory compliance in modern healthcare facilities.
Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
GlobeNewswire, Inc.
First clinical data for dapolsertib monotherapy: initial results from the Phase II JASPIS-01 study of dapolsertib (MEN1703), a first-in-class oral dual PIM/FLT3 kinase inhibitor, in patients with relapsed/refractory (r/r) aggressive B-cell...
NewAmsterdam Pharma Provides Corporate Update and Reports Third Quarter Financial Results
GlobeNewswire, Inc.
– Received European Commission approval for Ubeslo® (obicetrapib monotherapy) and Evlarco® (obicetrapib plus ezetimibe fixed-dose combination), marking the first regulatory approval of obicetrapib worldwide – – Initiated SPINOZA Phase 2b trial...
San Rocco Therapeutics Announces Major Advances Toward Clinical Development of MiNiRoLu™ Gene Therapy at ESGCT 2026
EIN Presswire
New manufacturing and therapeutic protein expression data support advancement of an investigational gene therapy for sickle cell disease and beta-thalassemia TAMPA, FL, UNITED STATES, November 3, 2026 /EINPresswire.com/ -- San Rocco...
EHMA Italian Chapter Explores How Neuroscience Is Redefining the Gastronomic Experience in Luxury Hospitality
EIN Presswire
The Italian Chapter Autumn Meeting, held alongside EHMA’s Extraordinary General Meeting, brought together European hospitality leaders to celebrate excellence.
Seres Therapeutics Announces Publication of SER-155 Phase 1b Results in Nature Medicine Showing Reduced Bloodstream Infections in Allogeneic Hematopoietic Cell Transplantation Recipients
GlobeNewswire, Inc.
Peer-reviewed publication reports a 77% relative risk reduction in bloodstream infections and significantly lower systemic antibiotic exposure with SER-155 compared with placebo Translational data from the study support the SER-155 mechanisms of...
ONWARD Medical Delivers Revenue of EUR 2.5M in Q3 2026, with Sustained Commercial Momentum and Strong Clinical Execution
GlobeNewswire, Inc.
EINDHOVEN, the Netherlands, Nov. 03, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord...
Global Pharmaceutical Company Commits to a Dual-Site Deal with AGC Biologics Exceeding €0.5 Billion
GlobeNewswire, Inc.
Agreement builds on customer’s long-term deal in new Yokohama facility for five commercial biologics programs, now allocating an additional six commercial programs to Copenhagen facility to consolidate high-volume, single-use biologics...
TRANSFORM II Selected as a Late-Breaking Clinical Trial at TCT 2026
EIN Presswire
TRANSFORM II Selected as a Late-Breaking Clinical Trial at TCT 2026 SAN DIEGO, CA, UNITED STATES, November 2, 2026 /EINPresswire.com/ -- TRANSFORM II randomized trial Selected as a Late-Breaking Clinical Trial at TCT 2026 International...
Alfasigma Announces New Linerixibat Data Across PBC and Liver Disease to be Presented at AASLD’s The Liver Meeting 2026
GlobeNewswire, Inc.
MORRISTOWN, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Alfasigma, a global pharmaceutical company, today announced that five presentations on linerixibat in primary biliary cholangitis (PBC), including one oral presentation and four posters, will be...
Italy Well-Being Report: 54 Indicators Up, 23 Down, Poverty Persists
MENAFN
(MENAFN) Italy has made gains in several areas of equitable and sustainable well-being, notably health and the environment, but poverty, stagnant disposable income and households’ struggle to make ends meet remain stubborn problems, according to...
Italy’s Quality of Life Improves in Some Areas, Financial Pressures Remain
MENAFN
(MENAFN) Italy has recorded improvements in several aspects of equitable and sustainable well-being, particularly in healthcare and environmental conditions, but continues to struggle with poverty, household disposable income and financial...
In-vitro Diagnostics Market to Reach US$ 218.73 Billion by 2034 at 7.8% CAGR, Driven by Rising Chronic Disease Burden and Advanced Diagnostic Technologies | Exclusive Report by The Insight Partners
GlobeNewswire, Inc.
New York, Oct. 30, 2026 (GLOBE NEWSWIRE) -- The global In-vitro Diagnostics Market is projected to grow from US$ 112.04 billion in 2025 to US$ 218.73 billion by 2034, registering a CAGR of 7.8% during 2026 to 2034, according to a new market study...
SETAF-AF civil affairs partners with U.S. Air Force to assess Kenyan military medical center
DVIDS - Georgia
VICENZA, Italy — Soldiers assigned to Civil Affairs Team Kenya, Civil Affairs Battalion, U.S. Army Southern European Task Force, Africa (SETAF-AF) partnered with a consolidated U.S. Air Force expeditionary medical support team to conduct a...
Top 10 Agitated Nutsche Filter Dryer Manufacturers in 2026: Advancing Pharmaceutical Production
EIN Presswire
A 2026 guide to ten agitated nutsche filter dryer manufacturers.
Beauty Diamond Medical & Aesthetics Introduces Matrix® Skin Renewal Platform: A Revolutionary Approach to Skin Health
EIN Presswire
Edmonton, AB clinic adds the Candela Matrix® platform, combining RF microneedling, fractional resurfacing and bulk heating in one treatment.
China's Pinghu Strengthens Business Ties with Italy
GlobeNewswire, Inc.
PINGHU, China, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Pinghu, a city in Zhejiang Province near Shanghai, is looking to expand its business links with Italy, with a focus on the luggage and apparel markets and the development of overseas warehouses for...
Sign up for:
Health Watch Italy
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.